Stock Scorecard

Stock Summary for Regencell Bioscience Holdings Ltd (RGC) - $12.87 as of 11/19/2025 9:21:30 PM EST

Total Score

9 out of 30

Safety Score

21 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for RGC

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for RGC

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for RGC

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for RGC

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for RGC (21 out of 100)

Stock Price Rating (Max of 10) 5
Historical Stock Price Rating (Max of 10) 1
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 4
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for RGC

Bragar Eagel & Squire, P.C. Is Investigating Regencell, Beyond Meat, Alvotech, and Camping World and Encourages Investors to Contact the Firm - Beyond Meat ( NASDAQ:BYND ) , Alvotech ( NASDAQ:ALVO ) 11/12/2025 10:01:00 PM
Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Other Big Stocks Moving Higher On Monday - Cogent Biosciences ( NASDAQ:COGT ) , e.l.f. Beauty ( NYSE:ELF ) 11/10/2025 3:01:00 PM
Beyond Meat's 1,600% 4-Day Rally Wasn't a Short Squeeze -- It Was Something Far More Dangerous 10/27/2025 7:51:00 AM
Lyft, Oruka Therapeutics, Roivant Sciences, Workday And Other Big Stocks Moving Higher On Wednesday - Robo.ai ( NASDAQ:AIIO ) , Blue Gold ( NASDAQ:BGL ) 9/17/2025 2:12:00 PM
1 Magnificent Stock-Split Stock Up 157,000% Since Its IPO to Buy in September, and 1 to Absolutely Avoid 9/3/2025 7:51:00 AM
1 Magnificent Stock-Split Stock to Buy Hand Over Fist in August and 1 to Absolutely Avoid 8/4/2025 7:51:00 AM
GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday - Arrowhead Pharma ( NASDAQ:ARWR ) , Abivax ( NASDAQ:ABVX ) 7/23/2025 3:00:00 PM
Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - Apogee Therapeutics ( NASDAQ:APGE ) , Apogee Enterprises ( NASDAQ:APOG ) 7/7/2025 10:26:00 AM
Olo, Tripadvisor, Aebi Schmidt Holding And Other Big Stocks Moving Higher On Thursday - BitMine Immersion Techs ( AMEX:BMNR ) , Aebi Schmidt Holding ( NASDAQ:AEBI ) 7/3/2025 2:39:00 PM
1 Magnificent Stock-Split Stock to Buy Hand Over Fist in July and 1 to Completely Avoid 7/1/2025 7:51:00 AM

Financial Details for RGC

Company Overview
Ticker RGC
Company Name Regencell Bioscience Holdings Ltd
Country USA
Description Regencell Bioscience Holdings Ltd is a pioneering biotechnology company based in Hong Kong that focuses on developing advanced therapeutic solutions to meet pressing healthcare needs. Utilizing proprietary research and development techniques, Regencell aims to create innovative treatments across various medical sectors, positioning itself at the forefront of biopharmaceutical advancements. As the global demand for cutting-edge healthcare solutions continues to rise, Regencell presents an attractive investment opportunity for institutional investors seeking exposure to a growth-oriented bioscience firm with significant market potential.
Sector Name HEALTHCARE
Industry Name DRUG MANUFACTURERS - SPECIALTY & GENERIC
Most Recent Quarter 12/31/2024
Next Earnings Date N/A

Stock Price History
Last Day Price 12.87
Price 4 Years Ago 0.84
Last Day Price Updated 11/19/2025 9:21:30 PM EST
Last Day Volume 108,872
Average Daily Volume 144,988
52-Week High 83.60
52-Week Low 0.09
Last Price to 52 Week Low 14,200.00%

Valuation Measures
Trailing PE N/A
Industry PE 77.61
Sector PE 115.35
5-Year Average PE -0.45
Free Cash Flow Ratio 1,287.00
Industry Free Cash Flow Ratio 12.22
Sector Free Cash Flow Ratio 27.55
Current Ratio Most Recent Quarter 41.92
Total Cash Per Share 0.01
Book Value Per Share Most Recent Quarter 0.01
Price to Book Ratio 1,281.94
Industry Price to Book Ratio 10.53
Sector Price to Book Ratio 33.20
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 2.50
Sector Price to Sales Ratio Twelve Trailing Months 16.69
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics
Total Shares Outstanding 494,489,000
Market Capitalization 6,364,073,430
Institutional Ownership 0.13%

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 26.73%
Reported EPS 12 Trailing Months -0.01
Reported EPS Past Year -34.15
Reported EPS Prior Year -0.08
Net Income Twelve Trailing Months -2,782,654
Net Income Past Year -4,301,837
Net Income Prior Year -5,871,130
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth -100.00%
Operating Margin Twelve Trailing Months 0.00%

Balance Sheet
Total Cash Most Recent Quarter 2,961,235
Total Cash Past Year 2,961,235
Total Cash Prior Year 1,564,795
Net Cash Position Most Recent Quarter 2,961,235
Net Cash Position Past Year 2,961,235
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 8,218,699
Total Stockholder Equity Prior Year 12,030,333
Total Stockholder Equity Most Recent Quarter 6,715,352

Free Cash Flow
Free Cash Flow Twelve Trailing Months -2,003,531
Free Cash Flow Per Share Twelve Trailing Months 0.00
Free Cash Flow Past Year -4,007,063
Free Cash Flow Prior Year -4,990,341

Options
Put/Call Ratio 0.14
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -0.95
MACD Signal -0.72
20-Day Bollinger Lower Band 11.60
20-Day Bollinger Middle Band 14.62
20-Day Bollinger Upper Band 17.65
Beta 2.00
RSI 37.91
50-Day SMA 9.35
150-Day SMA 3.36
200-Day SMA 2.72

System
Modified 11/18/2025 8:11:15 PM EST